2021
DOI: 10.1007/s40142-021-00200-7
|View full text |Cite
|
Sign up to set email alerts
|

Horizon Scanning in Cancer Genomics: How Advances in Genomic Medicine Will Change Cancer Care Over the Next Decade

Abstract: Purpose of Review Advances in genomic medicine have the potential to revolutionise cancer patient care by driving forwards the clinical practice of precision oncology. This review aims to outline how genomic medicine advances may alter the care of cancer patients and their families over the next 10 years. Recent Findings The translation of oncogenomic advances into the clinical environment will likely be facilitated by the increasing availability of next-g… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 42 publications
0
2
0
Order By: Relevance
“…Genomics has improved the diagnosis and treatment of diseases such as cancer (Brittain et al 2017;Peterson et al 2019;Seed 2021) and cardiac disease (Khera et al 2016;Pasipoularides 2018), and reduced healthcare costs and treatment burden for individuals (Bilkey et al 2019;Stark et al 2019). For example, the identification of BRCA gene variants for breast cancer or MSH2, MSH6 and MLH1 for colon and extracolonic cancers have resulted in screening programs and therapies that have changed the trajectory and outcomes of these diseases.…”
Section: Introductionmentioning
confidence: 99%
“…Genomics has improved the diagnosis and treatment of diseases such as cancer (Brittain et al 2017;Peterson et al 2019;Seed 2021) and cardiac disease (Khera et al 2016;Pasipoularides 2018), and reduced healthcare costs and treatment burden for individuals (Bilkey et al 2019;Stark et al 2019). For example, the identification of BRCA gene variants for breast cancer or MSH2, MSH6 and MLH1 for colon and extracolonic cancers have resulted in screening programs and therapies that have changed the trajectory and outcomes of these diseases.…”
Section: Introductionmentioning
confidence: 99%
“…Targeting identifiable, relevant gene pathways and networks specific to an individuals' genomic and molecular profile is a strategy that has been shown to improve treatment responses [2]. This genomically targeted personalized medicine strategy is effective across many medical disciplines, including oncology and neurology [2][3][4]. Components that convey individuality are of paramount importance for the successful treatment of ASD.…”
mentioning
confidence: 99%